Monday, August 25, 2025

From Market Darling to Punchline and Back Again?

Follow the Ivy at SummayMoney.com

Monday, August 25th 2025

Is The Stock with Ticker AI Finally a Buy?

Every few years, investors rediscover Plug Power (NASDAQ: PLUG) and wonder if the long-suffering hydrogen pioneer is finally about to turn the corner. Today, it's officially a penny stock, which means under $5 per share technically.

 

And that's a painful reminder that, adjusted for reverse splits, Plug's pre-dot com IPO price of $150 feels almost mythical compared to where the stock sits today.

 

Get the full details here

Sponsored
The Cross-Chain Giant Set for 1,000%+ Gains
As crypto markets surge, one multi-chain financial protocol is being targeted for massive institutional investment before retail discovers it. Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it – creating a coiled spring ready to release.  Click here to access our urgent research on this cross-chain opportunity.
Privacy Policy/Disclosures

Ivy Content you May Have Missed

Is The Stock with Ticker AI Finally a Buy?

C3.ai shares are back at price levels investors haven't seen since early 2023, and the reasons are downright concerning.

 

The artificial intelligence firm with ticker AI has endured a brutal year that began in January when the share price was cut in half. The torpedos keeping hitting the bow, as evidence by the latest business update that pointed to a steep revenue shortfall.

 

Get the full details here

Sponsored
"Partner" with Elon Musk on Project Colossus… Before September 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you to partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500. Click here to see how you could take a stake in Elon's private company…
Privacy Policy/Disclosures

1 Science Powerhouse To Own for the Next Decade

Thermo Fisher Scientific has a knack for thriving even in challenging markets. While the company isn't entirely immune to today's global headwinds, slower biopharmaceutical spending, tighter budgets in academic labs, and muted demand in China, it has weathered the storm far better than most of its peers.

 

The reason?

 

A combination of unmatched scale, an almost encyclopedic product catalog, and a distribution network so vast it can reach nearly twice as many customers as its largest competitors.

 

Get the full details here

Sponsored
Elon's Greatest Invention… Hidden in South Memphis?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after September 1st , it could be too late.
Privacy Policy/Disclosures

Can This Stock Double Your Money by 2030?

Over the last five years, Altria's share price climbed by just over 50%, but that's only part of the story. When you factor in dividends, a payout the company has raised for 55 consecutive years, total returns swell to over 120%.

 

That streak includes 59 separate payout bumps, and with today's yield hovering around 6.36%, management has every incentive to keep the tradition alive.

 

Get the full details here

- G. O'Fiachra

 

The Ivy by Summa Money | World Class Investing

 

We value your feedback: Please let us know what you think about our investing ideas so far, and any recommendations you may have for increasing the value of this newsletter. Please follow this link for a quick, 2-minute survey

You Might Also Like:

Follow the Burst at SummayMoney.com

Advertising Disclosure: This email may contain paid advertisements.

Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world.

We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive.

If you do not want to receive emails from us, you can follow this link to unsubscribe. or click the unsubscribe link at the bottom of the email that you do not want to receive.

If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com.

Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here.

If you can't see this message, view it in your browser.

You are receiving this e-mail at stevenmagallanes520.nims@blogger.com as a part of your free subscription to the Ivy Newsletter.

To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe.

To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311

Website: Summa Money

Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice.

Copyright 2024 Summa Money. All rights reserved.

If you do not want to receive emails from us, you can follow this link to unsubscribe. FROM THE IVY NEWSLETTER

Advertise With Us

No comments:

Page List

Blog Archive

Search This Blog

USAO - California, Northern News Update

Offices of the United States Attorneys You are subsc...